Reference
1. Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, et al. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. Journal of thrombosis and haemostasis : JTH. 2017;15(2):312-22.
2. Caltik A, Demircin G, Bülbül M, Erdogan O, Akyüz SG, Arda N. An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy. Rheumatology international. 2013;33(1):219-22.
3. Simmons SC, Smith ML, Chang-Miller A, Keddis MT. Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature. American journal of nephrology. 2015;42(6):451-9.
4. Li QY, Yu F, Zhou FD, Zhao MH. Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study. Medicine. 2016;95(18):e3595.
5. Sun F, Wang X, Wu W, Wang K, Chen Z, Li T, et al. TMA secondary to SLE: rituximab improves overall but not renal survival. Clinical rheumatology. 2018;37(1):213-8.